Protagenic Therapeutics, Inc.
PTIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,525 | -$5,000 | -$3,556 | -$4,523 |
| Dep. & Amort. | $50 | $28 | $0 | $427 |
| Deferred Tax | $0 | $0 | $0 | -$427 |
| Stock-Based Comp. | $923 | $667 | $865 | $1,519 |
| Change in WC | $468 | -$114 | $540 | -$140 |
| Other Non-Cash | -$132 | $716 | $157 | $346 |
| Operating Cash Flow | -$4,217 | -$3,704 | -$1,994 | -$2,799 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$150 | -$2 | $0 |
| Net Acquisitions | $0 | $0 | $46 | $0 |
| Inv. Purchases | -$297 | -$2,764 | -$34 | -$10,396 |
| Inv. Sales/Matur. | $3,048 | $7,690 | $1,633 | $486 |
| Other Inv. Act. | $52 | $0 | -$46 | $0 |
| Investing Cash Flow | $2,803 | $4,775 | $1,597 | -$9,910 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,964 | $0 | $0 | $11,708 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | $0 | $870 |
| Financing Cash Flow | $1,964 | $0 | $0 | $12,578 |
| Forex Effect | $1 | $1 | $71 | $1 |
| Net Chg. in Cash | $551 | $1,073 | -$326 | -$130 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,288 | $215 | $541 | $671 |
| End Cash | $1,838 | $1,288 | $215 | $541 |
| Free Cash Flow | -$4,217 | -$3,854 | -$1,996 | -$2,799 |